top of page
Second Generation LAI for Schizophrenia
Second generation long-acting injectable antipsychotic drugs are associated with a reduced number of adverse outcomes for treating patients newly diagnosed with schizophrenia, according to a study published in Schizophrenia Research.
bottom of page